Skip to main content
. 2016 Jun 27;7(1):37–44. doi: 10.1016/j.jegh.2016.06.001

Table 1.

Demographic data and clinical characteristics of study participants.

Characteristic Overall mean ± SD n (%) Non-OSA mean ± SD n (%) OSA mean ± SD n (%) p
Patients (No. (%)) 157 (100.0) 60 (38.2) 97 (61.8) NA
Age (y) 45.3 ± 13.5 39.5 ± 14 48.9 ± 11.9 0.01
Gender:
  Male 96 (61.2) 33 (55.0) 63 (65.0) 0.21
  Female 61 (38.9) 27 (45.0) 34 (35.1)
Smokers 27 (17.2) 12 (20.0) 15 (15.5) 0.46
Ex-smokers 49 (31.2) 13 (21.7) 36 (37.1) 0.04
Snoring:
  Yes 122 (77.7) 34 (56.7) 88 (90.7) 0.01
  No 23 (14.7) 18 (30.0) 5 (5.2)
  Unknown 12 (7.7) 8 (13.3) 4 (4.1)
AHI (median, IQR) 11.2 (1.7–32.4) 0.4 (0.0–2.8) 26.8 (12.4–45.7) 0.01
% of sleep time with O2 saturation below 90%, median (IQR) 1.4 (0.0–25.9) 0 (0–0.5) 7.6 (0.9–45.5) 0.01
Weight (kg) 97 ± 29.2 78.3 ± 18.5 108.5 ± 28.8 0.01
Height (cm) 164 ± 10.5 164 ± 10.3 164 ± 10.7 0.97
BMI (kg/m2) 37.4 ± 15.6 29.1 ± 7.1 42.5 ± 17.1 0.01
Neck circumference (inches) 15.9 ± 2 14.8 ± 1.7 16.6 ± 1.9 0.01
ESS score 12 ± 6.1 10.4 ± 6.1 12.9 ± 6 0.01
BQ score
  High risk 120 (76.4) 32 (53.3) 88 (90.7) 0.01
  Low risk 37 (23.6) 28 (46.7) 9 (9.3)
Allergic rhinitis 86 (54.8) 35 (58.3) 51 (52.6) 0.50
Bronchial asthma 81 (51.6) 33 (55.0) 48 (49.5) 0.50
Diabetes mellitus 52 (33.1) 16 (26.7) 36 (37.1) 0.18
Hypertension 72 (45.9) 17 (28.3) 55 (56.7) 0.01
Stroke 10 (6.4) 2 (3.3) 8 (8.3) 0.22
IHD 23 (14.7) 3 (5.0) 20 (20.6) 0.01
GERD 70 (44.6) 20 (33.3) 50 (51.6) 0.03
COPD 10 (6.4) 2 (3.3) 8 (8.3) 0.32

AHI, apnea-hypopnea index; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CI: Confidence interval; ESS, Epworth Sleepiness Scale; GERD, gastroesophageal reflux disease; IHD, ischemic heart disease; SD, standard deviation.